NCT00000767View on ClinicalTrials.gov

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

July 31, 1996

Conditions

HIV Infections

Interventions

BIOLOGICAL

TBC-3B Vaccine

BIOLOGICAL

Smallpox Vaccine

Trial Locations (5)

14642

Univ. of Rochester AVEG, Rochester

37232

Vanderbilt Univ. Hosp. AVEG, Nashville

63104

St. Louis Univ. School of Medicine AVEG, St Louis

98144

UW - Seattle AVEG, Seattle

Unknown

JHU AVEG, Pittsburgh

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000767 - A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B) | Biotech Hunter | Biotech Hunter